Novavax CEO Rahul Singhvi - An Interview With “The Pink Sheet” DAILY
Vaccine firm tells "The Pink Sheet" DAILY about its virus-like particles process for making vaccines and how its processes can be less expensive and require smaller facilities.
Vaccine firm tells "The Pink Sheet" DAILY about its virus-like particles process for making vaccines and how its processes can be less expensive and require smaller facilities.